DAVID SHROCK: Open Payments
NPI 1104288679 · JACKSON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$335 in 16 payments from 8 companies in 2025. Trend: 2023 $498 · 2024 $557 · 2025 $335
Food & beverage: $335
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $108 |
| Alexion Pharmaceuticals, Inc. | 2 | $68 |
| Viatris Specialty LLC | 2 | $44 |
| PFIZER INC. | 2 | $38 |
| Enterra Medical, Inc. | 1 | $21 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $20 |
| Inari Medical, Inc. | 1 | $20 |
| Amgen Inc. | 1 | $16 |
Products named: TEFLARO, ULTOMIRIS, YUPELRI, NURTEC ODT, XIFAXAN, FLOWTRIEVER CATHETER, S, ELIQUIS, EVENITY.
Industry payments across MS — which companies pay providers there.
